# EDGAR Filing Document

**Accession Number:** 0001900304
**File Stem:** 0001654954-26-005059
**Filing Date:** 2026-5
**Character Count:** 6191
**Document Hash:** 0ce3ff34ea264f89cf15a0cf23785b9b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-26-005059.hdr.sgml**: 20260518

**ACCESSION NUMBER**: 0001654954-26-005059

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260518

**FILED AS OF DATE**: 20260518

**DATE AS OF CHANGE**: 20260518

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Haleon plc
- **CENTRAL INDEX KEY:** 0001900304
- **STANDARD INDUSTRIAL CLASSIFICATION:** PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41411
- **FILM NUMBER:** 26991766

**BUSINESS ADDRESS:**
- **STREET 1:** BUILDING 5, FIRST FLOOR
- **STREET 2:** THE HEIGHTS
- **CITY:** WEYBRIDGE
- **STATE:** X0
- **ZIP:** KT13 0NY
- **BUSINESS PHONE:** 44 1932 822000

**MAIL ADDRESS:**
- **STREET 1:** BUILDING 5, FIRST FLOOR
- **STREET 2:** THE HEIGHTS
- **CITY:** WEYBRIDGE
- **STATE:** X0
- **ZIP:** KT13 0NY

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DRVW 2022 Ltd
- **DATE OF NAME CHANGE:** 20211217

**UNITED STATES**

 **SECURITIES AND EXCHANGE COMMISSION**

 **Washington, D.C. 20549**

 **FORM 6-K**

 **REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934**

 **For the month of May 2026**

 **Commission File Number: 001-41411**

 **Haleon plc**

(Translation of registrant's name into English)

 **Building 5, First Floor, The Heights,**

 **Weybridge, Surrey, KT13 0NY**

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

 **EXHIBIT INDEX**

<u> <u>Exhibit Number</u> </u> <u> <u>Description</u> </u> <br> <u> 99.1 </u> <u> 18 May 2026 - Director/PDMR Shareholding </u>

99.1 ![](a7691e000.jpg)

**Haleon plc**: **Director/PDMR Shareholding** 

 **18 May 2026:** Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today announces notification and public disclosure in accordance with the requirements of The UK Market Abuse Regulation of Transactions by a Person Discharging Managerial Responsibilities ("PDMR").

On 15 May 2026, the Company received notification of the following transaction as detailed below.

---

| | | | |
|:---|:---|:---|:---|
| **1** <br>| **Details of the issuer, emission allowance market participant** | **Details of the issuer, emission allowance market participant** | **Details of the issuer, emission allowance market participant** |
| a) <br>| Name <br>| Haleon plc | Haleon plc |
| b) <br>| LEI <br>| 549300PSB3WWEODCUP19  | 549300PSB3WWEODCUP19  |
| **2** <br>| **Reason for the notification**  | **Reason for the notification**  | **Reason for the notification**  |
| a) <br>| Position/status <br>| Senior Independent Non-Executive Director | Senior Independent Non-Executive Director |
| b) <br>| Initial notification /Amendment <br>| Initial Notification  | Initial Notification  |
| **3** <br>| **Details of the person discharging managerial responsibilities / person closely associated ("PCA")**  | **Details of the person discharging managerial responsibilities / person closely associated ("PCA")**  | **Details of the person discharging managerial responsibilities / person closely associated ("PCA")**  |
| a) <br>| PDMR/PCA  | PDMR  | PDMR  |
| b) <br>| Name<br>| Alan Stewart | Alan Stewart |
| **4** <br>| **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted**  | **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted**  | **Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted**  |
| a) <br>| Description of Instrument <br>Identification code <br>| Share<br>GB00BMX86B70  | Share<br>GB00BMX86B70  |
| b) <br>| Nature of the transaction <br>| Acquisition of Ordinary Shares as a result of dividend reinvestment | Acquisition of Ordinary Shares as a result of dividend reinvestment |
| c)  | Currency, Price(s) and volume(s)  |  |  |
| c)  |  | Price(s) <br>| Volume(s)  |
| c)  |  | £3.3105<br>| 498 |
| c)  |  |  |  |
| d)  | Aggregated information  |  |  |
| d)  |  |  |  |
| d)  | - Aggregated volume  | N/A | N/A |
| d)  |  |  |  |
| d)  | - Price  |  |  |
| d)  |  |  |  |
| e) <br>| Date of the transaction <br>| 14 May 2026 | 14 May 2026 |
| f) <br>| Place of the transaction <br>| London Stock Exchange (XLON)  | London Stock Exchange (XLON)  |

---

 **Amanda Mellor**

 **Company Secretary**

 **About Haleon**

Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as *Advil*, *Centrum*, *Otrivin*, *Panadol*, *parodontax*, *Polident*, *Sensodyne*, *Theraflu* and *Voltaren* - are trusted by more than one billion consumers and are recommended by health professionals around the world.

For more information, please visit <u>www.haleon.com</u>.

 **SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  | **HALEON PLC**<br> *(Registrant)* | **HALEON PLC**<br> *(Registrant)* |
| Date: May 18, 2026 | By: | /s/ Amanda Mellor | /s/ Amanda Mellor |
|  |  | Name: | Amanda Mellor |
|  |  | Title: | Company Secretary |

---

<br>